Applied Therapeutics, Inc.
APLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,000 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $9,923 | $7,837 | $11,695 |
| Gross Profit | $1,000 | -$9,923 | -$7,837 | -$11,695 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $9,601 | $9,923 | $7,837 | $11,695 |
| G&A Expenses | $9,366 | $12,969 | $17,482 | $21,164 |
| SG&A Expenses | $9,366 | $13,175 | $17,688 | $21,327 |
| Sales & Mktg Exp. | $0 | $206 | $206 | $163 |
| Other Operating Expenses | -$1,209 | -$9,923 | -$7,837 | -$11,695 |
| Operating Expenses | $17,758 | $13,175 | $17,688 | $21,327 |
| Operating Income | -$16,758 | -$23,098 | -$25,525 | -$33,022 |
| % Margin | -1,675.8% | – | – | – |
| Other Income/Exp. Net | -$2,232 | $1,768 | $3,700 | $77,029 |
| Pre-Tax Income | -$18,990 | -$21,330 | -$21,825 | $44,007 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18,990 | -$21,330 | -$21,825 | $44,007 |
| % Margin | -1,899% | – | – | – |
| EPS | -0.13 | -0.15 | -0.15 | 0.32 |
| % Growth | 13.3% | 0% | -146.9% | – |
| EPS Diluted | -0.13 | -0.15 | -0.15 | 0.32 |
| Weighted Avg Shares Out | 145,560 | 145,091 | 144,788 | 139,535 |
| Weighted Avg Shares Out Dil | 145,560 | 145,091 | 144,788 | 139,535 |
| Supplemental Information | – | – | – | – |
| Interest Income | $144 | $364 | $621 | $962 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $111 | $1 | $0 | $0 |
| EBITDA | -$18,879 | -$23,098 | -$25,525 | -$33,022 |
| % Margin | -1,887.9% | – | – | – |